Riemann K - Search Results

1

[Paraganglioma in the area of the head and neck. A review of molecular genetic research].

Braun S, Riemann K, Pusch CM, Sotlar K, Pfister M, Kupka S. Braun S, et al. Among authors: riemann k. HNO. 2004 Jan;52(1):11-7. doi: 10.1007/s00106-003-0959-y. HNO. 2004. PMID: 14740109 Review. German.

2

[Mitochondrial hearing impairment. Background, genetic predisposition and possibilities for diagnosis].

Riemann K, Pfister M, Blin N, Kupka S. Riemann K, et al. HNO. 2004 Jun;52(6):503-9. doi: 10.1007/s00106-003-0993-9. HNO. 2004. PMID: 15241512 Review. German.

3

Chromosome 11 monosomy in conjunction with a mutated SDHD initiation codon in nonfamilial paraganglioma cases.

Riemann K, Sotlar K, Kupka S, Braun S, Zenner HP, Preyer S, Pfister M, Pusch CM, Blin N. Riemann K, et al. Cancer Genet Cytogenet. 2004 Apr 15;150(2):128-35. doi: 10.1016/j.cancergencyto.2003.10.013. Cancer Genet Cytogenet. 2004. PMID: 15066320

4

Active succinate dehydrogenase (SDH) and lack of SDHD mutations in sporadic paragangliomas.

Braun S, Riemann K, Kupka S, Leistenschneider P, Sotlar K, Schmid H, Blin N. Braun S, et al. Among authors: riemann k. Anticancer Res. 2005 Jul-Aug;25(4):2809-14. Anticancer Res. 2005. PMID: 16080530 Free article.

5

GJB2 mutations in patients with non-syndromic hearing loss from Northeastern Hungary.

Tóth T, Kupka S, Haack B, Riemann K, Braun S, Fazakas F, Zenner HP, Muszbek L, Blin N, Pfister M, Sziklai I. Tóth T, et al. Among authors: riemann k. Hum Mutat. 2004 Jun;23(6):631-2. doi: 10.1002/humu.9250. Hum Mutat. 2004. PMID: 15146474

6

No association of the NF-kappaB1 -94ins/delATTG promoter polymorphism with relapse-free and overall survival in patients with squamous cell carcinomas of the head and neck region.

Lehnerdt GF, Bankfalvi A, Grehl S, Adamzik M, Lang S, Schmid KW, Siffert W, Riemann K. Lehnerdt GF, et al. Among authors: riemann k. Int J Immunopathol Pharmacol. 2008 Oct-Dec;21(4):827-32. doi: 10.1177/039463200802100407. Int J Immunopathol Pharmacol. 2008. PMID: 19144268 Free article.

7

Phase I dose-escalation study of volasertib in pediatric patients with acute leukemia or advanced solid tumors.

Doz F, Locatelli F, Baruchel A, Blin N, De Moerloose B, Frappaz D, Dworzak M, Fischer M, Stary J, Fuertig R, Riemann K, Taube T, Reinhardt D. Doz F, et al. Among authors: riemann k. Pediatr Blood Cancer. 2019 Oct;66(10):e27900. doi: 10.1002/pbc.27900. Epub 2019 Jul 5. Pediatr Blood Cancer. 2019. PMID: 31276318 Clinical Trial.

8

DNA repair gene XRCC1 polymorphisms and outcome of renal cell carcinoma in Caucasian patients.

Bachmann HS, Rübben H, Schmid KW, Siffert W, Riemann K. Bachmann HS, et al. Among authors: riemann k. Anticancer Res. 2009 Dec;29(12):5131-5. Anticancer Res. 2009. PMID: 20044627 Free article.

9

Association of GNB4 intron-1 haplotypes with survival in patients with UICC stage III and IV colorectal carcinoma.

Riemann K, Struwe H, Alakus H, Obermaier B, Schmitz KJ, Schmid KW, Siffert W. Riemann K, et al. Anticancer Res. 2009 Apr;29(4):1271-4. Anticancer Res. 2009. PMID: 19414374 Free article.

10

Insertion/deletion polymorphism in the promoter of NFKB1 as a potential molecular marker for the risk of recurrence in superficial bladder cancer.

Riemann K, Becker L, Struwe H, Rübben H, Eisenhardt A, Siffert W. Riemann K, et al. Int J Clin Pharmacol Ther. 2007 Aug;45(8):423-30. doi: 10.5414/cpp45423. Int J Clin Pharmacol Ther. 2007. PMID: 17725175

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

35 results

Search Page

Filters